ANIX
Anixa Biosciences Inc (ANIX
NASDAQ · Healthcare · Biotechnology · US
$2.77
+0.36%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-72.0%
Return on equity
-69.1%
Return on assets
-74.9%
Return on invested capital
0.00x
Asset turnover
-$7.4M
Cash from operations
$0.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026